Literature DB >> 1918365

Killing of gram-negative bacteria by lactoferrin and lysozyme.

R T Ellison1, T J Giehl.   

Abstract

Although lactoferrin has antimicrobial activity, its mechanism of action is not full defined. Recently we have shown that the protein alters the Gram-negative outer membrane. As this membrane protects Gram-negative cells from lysozyme, we have studied whether lactoferrin's membrane effect could enhance the antibacterial activity of lysozyme. We have found that while each protein alone is bacteriostatic, together they can be bactericidal for strains of V. cholerae, S. typhimurium, and E. coli. The bactericidal effect is dose dependent, blocked by iron saturation of lactoferrin, and inhibited by high calcium levels, although lactoferrin does not chelate calcium. Using differing media, the effect of lactoferrin and lysozyme can be partially or completely inhibited; the degree of inhibition correlating with media osmolarity. Transmission electron microscopy shows that E. coli cells exposed to lactoferrin and lysozyme at 40 mOsm become enlarged and hypodense, suggesting killing through osmotic damage. Dialysis chamber studies indicate that bacterial killing requires direct contact with lactoferrin, and work with purified LPS suggests that this relates to direct LPS-binding by the protein. As lactoferrin and lysozyme are present together in high levels in mucosal secretions and neutrophil granules, it is probable that their interaction contributes to host defense.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918365      PMCID: PMC295557          DOI: 10.1172/JCI115407

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

1.  Bactericidal effect of lactoferrin on Legionella pneumophila.

Authors:  C A Bortner; R D Miller; R R Arnold
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2.

Authors:  R C Goldman; L Leive
Journal:  Eur J Biochem       Date:  1980

3.  Aberrant migration of lipopolysaccharide in sodium dodecyl sulfate/polyacrylamide gel electrophoresis.

Authors:  P J Hitchcock
Journal:  Eur J Biochem       Date:  1983-07-01

Review 4.  Role of iron in microbe-host interactions.

Authors:  R A Finkelstein; C V Sciortino; M A McIntosh
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

5.  The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.

Authors:  J Weiss; K Muello; M Victor; P Elsbach
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane.

Authors:  R E Hancock; P G Wong
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

7.  Polycations sensitize enteric bacteria to antibiotics.

Authors:  M Vaara; T Vaara
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

8.  Polycations as outer membrane-disorganizing agents.

Authors:  M Vaara; T Vaara
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

9.  Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.

Authors:  R J Martinez; S F Carroll
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

10.  Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria.

Authors:  J Weiss; M Victor; P Elsbach
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more
  162 in total

Review 1.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  Joseph P Dillard; Kathleen T Hackett
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

5.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in HeLa cells.

Authors:  C Longhi; M P Conte; L Seganti; M Polidoro; A Alfsen; P Valenti
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

Review 7.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 8.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 9.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

10.  Expression of human lactoferrin in milk of transgenic mice.

Authors:  G J Platenburg; E P Kootwijk; P M Kooiman; S L Woloshuk; J H Nuijens; P J Krimpenfort; F R Pieper; H A de Boer; R Strijker
Journal:  Transgenic Res       Date:  1994-03       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.